Clinical trial
A Phase 2 Study Of PF-00232798 In HIV Positive Patients
NCT00495677 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00495677 |
|---|---|
| Title | A Phase 2 Study Of PF-00232798 In HIV Positive Patients |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Multicentre Study In Asymptomatic Hiv-Infected Patients To Investigate The Pharmacodynamics, Pharmacokinetics, Safety And Toleration Of PF-00232798 |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug |
| Interventions | PF-00232798 |
| Enrollment | 43 |
| Start date | Jun 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | Oct 30, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: